| Name | 1,1,1-triphenyl-N-(pyridin-3-ylmethyl)methanamine |
|---|---|
| Synonyms |
hms3261b11
hms3269l03 ucl 2077 |
| Description | UCL 2077 is a selective slow-afterhyperpolarization (sAHP) channel blocker (IC50 = 500 nM in hippocampal neurons in culture), having minimal effects on Ca2+ channels, action potentials, input resistance and the medium after hyperpolarization[1]. UCL 2077 is also a subtype-selective blocker of the epilepsy associated KCNQ channels[2]. |
|---|---|
| Related Catalog | |
| Target |
sAHP[1]. |
| References |
| Molecular Formula | C25H22N2 |
|---|---|
| Molecular Weight | 350.46 |
| Exact Mass | 350.17800 |
| PSA | 24.92000 |
| LogP | 5.55420 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn |
| RIDADR | NONH for all modes of transport |